VAERS Explorer
Back to explore

Report #2868906

Received Oct 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNK—OT

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

received two doses of a flu vaccine within a 40 minute time period with no reported adverse event; Initial information received on 21-Oct-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who received two doses of Influenza USP Trival A-B Subvirion No Preservative Vaccine [Fluzone] within a 40-minutes time period with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown 2 doses of suspect Influenza USP Trival A-B Subvirion No Preservative Vaccine Suspension for injection (lot number, strength and expiry date-unknown) via unknown route in unknown administration site for Influenza (Influenza immunisation) within a 40-minutes time period with no reported adverse event (extra dose administered) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.